Description

The IVD (in vitro diagnostic) market in China in terms of revenue is set to grow by US$ 26 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 19.4% during the forecast period, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for IVD (in vitro diagnostic). The China IVD (in vitro diagnostic) market is segmented on the basis of type. By type, it is categorized into clinical chemistry, hematology and body fluid, immunoassay, microbiology, molecular diagnostics, POCT (point-of-care testing), and others. The immunoassay segment held the largest market share of 31.1% in 2020.

The report has profiled some of the key players of the market such as Abbott Laboratories International Co., Danaher Corporation, Roche Holding AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Siemens AG, Sysmex Corporation.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the IVD (in vitro diagnostic) market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Type: clinical chemistry, hematology and body fluid, immunoassay, microbiology, molecular diagnostics, POCT (point-of-care testing), and others
Years Considered: this report covers the period 2017 to 2027

Key Benefits for Stakeholders

Get a comprehensive picture of the China IVD (in vitro diagnostic) market
Pinpoint growth sectors and trends for investment
Understand what the future of the IVD (in vitro diagnostic) market in China looks like
Identify the competitive landscape and window of opportunity

Table of Contents

1. Market Definition
2. Research Methodology
3. Market Data & Outlook
3.1 Market Value
3.2 Market Value Forecast
4. IVD (In Vitro Diagnostic) Market by Type
4.1 Clinical Chemistry
4.2 Hematology And Body Fluid
4.3 Immunoassay
4.4 Microbiology
4.5 Molecular Diagnostics
4.6 Poct (Point-Of-Care Testing)
4.7 Others
5. Company Profiles
5.1 Abbott Laboratories International Co.
5.2 Danaher Corporation
5.3 Roche Holding AG
5.4 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
5.5 Siemens AG
5.6 Sysmex Corporation
6. Appendix
6.1 About StrategyHelix
6.2 Disclaimer